NASDAQ:SYRE | EBITDA | Spyre Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2014-12-31 to 2025-12-31
Data captured

Historical EBITDA

DateEBITDA
2024-12-31-$61.25M
2024-03-31-$47.77M
2023-12-31-$45.91M
2023-03-31-$18.42M
2022-12-31-$18.78M
2022-03-31-$24.04M
2021-12-31-$20.03M
2021-03-31-$17.85M
2020-12-31-$22.41M
2020-03-31-$18.87M
2019-12-31-$21.8M
2019-03-31-$17.56M
2018-12-31-$15.23M
2018-03-31-$8.18M
2017-12-31-$6.56M
2017-03-31-$6.28M
2016-12-31-$5.51M
2016-03-31-$4.54M
2015-12-31-$3.97M
2015-03-31-$2.45M

Annual EBITDA

DateEBITDA
2025-12-31-$209.56M
2024-12-31-$208.57M
2023-12-31-$241.56M
2022-12-31-$83.21M
2021-12-31-$64.07M
2020-12-31-$80.49M
2019-12-31-$79.92M
2018-12-31-$45.17M
2017-12-31-$27.43M
2016-12-31-$21.77M
2015-12-31-$11.23M
2014-12-31-$8.89M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.